What does stable disease mean on my Liver Cancer scan results
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding "Stable Disease" on Your Liver Cancer Scan
Great question—this is an important finding to understand. Let me explain what "stable disease" means and why it matters for your care.
What Stable Disease Means
Stable disease means your cancer is not growing and not shrinking based on the measurements on your scan. The tumors are essentially staying the same size compared to your previous imaging.
Here's how doctors typically categorize scan results:
- Complete response: All tumors disappear
- Partial response: Tumors shrink by 30% or more
- Stable disease: Tumors stay roughly the same size (less than 30% growth or shrinkage)
- Progressive disease: Tumors grow by 20% or more
Why Stable Disease Can Actually Be Good News
This might seem counterintuitive, but stable disease is often considered a positive outcome, especially in advanced liver cancer. Here's why:
According to discussions in cancer care literature, doctors recognize that stable disease can be meaningful even without tumor shrinkage. As one expert noted: "If I can get my disease to stop spreading, one day, I'll die of a heart attack or get hit by a bus. That seems like a pretty good option."
The key point: Stopping cancer growth is a real benefit, even if the tumors don't get smaller. This gives your body time and allows your treatment to work without the disease advancing.
Important Context for Liver Cancer
For hepatocellular carcinoma (HCC) and other liver cancers, stable disease is particularly relevant because:
- Treatment goals vary - Not all treatments aim for tumor shrinkage. Some are designed specifically to stop growth
- Quality of life matters - If your disease is stable AND you're tolerating treatment well, that's a "win-win" scenario
- Time is valuable - Stable disease buys time for new treatment options to become available or for your body to respond better over time
What You Should Ask Your Oncologist
Since stable disease can mean different things depending on your specific situation, here are important questions to discuss:
- "Is my stable disease considered a good response to my current treatment?" - Your doctor can explain whether this is the expected outcome or if adjustments might help
- "How long has my disease been stable, and what does that tell us?" - Duration matters; longer stability is generally better
- "Are there any concerning changes in the scan besides size measurements?" - Doctors look at more than just tumor measurements (blood flow, density, location)
- "What's our plan if the disease remains stable?" - Will you continue current treatment, adjust it, or monitor closely?
- "What would trigger a change in my treatment plan?" - Understanding the decision-making helps you stay informed
Important Note on Scan Interpretation
It's worth knowing that scan interpretation has evolved. According to recent clinical guidance, doctors now use updated assessment criteria (like RECIST 2.0) that help standardize how they measure and interpret results. Your oncologist is using these evidence-based standards to evaluate your scans.
Next Steps
The most important thing is to discuss your specific scan results with your oncologist in detail. They can explain:
- How your current scan compares to previous ones
- Whether stable disease is the expected response to your treatment
- Any other findings on the scan beyond size measurements
- Your personalized treatment plan going forward
Stable disease often represents real progress in cancer care, and your doctor can help you understand exactly what it means for your individual situation.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Liver Cancer (2026)Browse all NCCN Guidelines for Patients →Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: